Managing Director. Over 30 years experience in pharmaceutical and biotechnology industry with 20 years in global business development and 10 years in R&D. As Vice President of Search & Evaluation within the Global Business Development and the Center for External Innovation groups at Takeda Pharmaceuticals Terry oversaw the identification, evaluation and due diligence of multiple licensing and M&A opportunities across Therapeutic areas that included CV-Metabolic, GI, Immunology-respiratory and CNS. Prior to Takeda, Terry was Vice President of External Science and Technology at GSK, he co-led negotiations in GSK’s $450 million acquisition of Domantis, the largest such deal at the time. Previously headed GSK Oncology Licensing worldwide. Licensing experience covers protein-based agents and conventional small molecules as well as cutting edge science and technology platforms. Core member of a number Pharma senior management committees, including Takeda’s Business Development & Licensing Committee and GSK’s most senior R&D scientific review and governance committee for technology platforms and compounds up to clinical proof-of-concept. BSc (Hons) in Biochemistry. Ph.D. in Chemistry from the University of Manchester, UK.